The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial

医学 免疫学 自身免疫 临床试验 白细胞介素 内科学 细胞因子 免疫系统
作者
Roberta Lorenzon,Claire Ribet,Fabien Pitoiset,S. Aractingi,Beatrice Banneville,Laurent Beaugerie,Françis Berenbaum,P. Cacoub,Julien Champey,Olivier Chazouillères,Christophe Corpechot,Bruno Fautrel,A. Mékinian,Elodie Régnier,David Saadoun,Joe‐Elie Salem,Jérémie Sellam,Philippe Seksik,Éric Vicaut,Michèlle Rosenzwajg
出处
期刊:Journal of Autoimmunity [Elsevier BV]
卷期号:144: 103172-103172 被引量:19
标识
DOI:10.1016/j.jaut.2024.103172
摘要

A Tregs insufficiency is central to autoimmune and inflammatory diseases pathophysiology and low dose interleukin-2 (IL-2LD) can specifically activate Tregs. To assess IL-2LD therapeutic potential and select diseases for further clinical development, we performed an open-label, phase 2a, disease-finding, "basket trial" involving patients with one of 13 different autoimmune diseases. 81 patients treated with IL-2LD (1 million IU/day) for 5 days, followed by fortnightly injections. The first 48 patients received diluted Proleukin®, while the subsequent 33 received ready-to-use ILT-101®. The primary endpoint was the change in Tregs at day-8 compared to baseline. Key secondary endpoints included clinical efficacy assessments using the Clinical Global Impression (CGI) scale, disease-specific scores, and EuroQL-5D-5L. Our study unveiled a universal and significant expansion and activation of Tregs, without concomitant Teffs activation, across all 13 autoimmune diseases. Both Proleukin® and ready-to-use ILT-101® demonstrated identical effects on Tregs. CGI scores reflecting activity, severity, and efficacy were significantly reduced in the overall patient population. Disease-specific clinical scores improved in five of the six disease cohorts with at least six patients, namely ankylosing spondylitis, systemic lupus erythematosus, Behçet's disease, Sjögren's syndrome, and systemic sclerosis. Urticaria was the only severe adverse event related to treatment. IL-2LD was well-tolerated, exhibiting specific Treg activation and clinical improvements across the 13 autoimmune diseases. Tregs stimulation by IL-2LD is a promising therapeutic strategy and IL-2LD holds considerable promise for integration into combinatorial therapeutic approaches.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
1秒前
znn发布了新的文献求助10
2秒前
无奈行恶应助唱歌不着调采纳,获得10
2秒前
Lily完成签到,获得积分10
3秒前
清脆万声完成签到,获得积分20
3秒前
共享精神应助多金采纳,获得10
3秒前
Owen应助老迟到的沛萍采纳,获得10
4秒前
在水一方应助火火采纳,获得10
5秒前
kk发布了新的文献求助10
5秒前
小羽完成签到,获得积分10
5秒前
5秒前
5秒前
6秒前
mzh发布了新的文献求助10
6秒前
zhang_rx完成签到,获得积分20
6秒前
6秒前
MXG完成签到,获得积分10
7秒前
7秒前
淡淡诗柳发布了新的文献求助10
7秒前
小马甲应助论太刀虾采纳,获得10
7秒前
酷波er应助Xenia采纳,获得10
8秒前
LioXH发布了新的文献求助10
8秒前
lxp完成签到,获得积分10
9秒前
果泥关注了科研通微信公众号
10秒前
10秒前
10秒前
太阳完成签到 ,获得积分10
10秒前
10秒前
pkubest发布了新的文献求助10
11秒前
11秒前
量子星尘发布了新的文献求助10
11秒前
MXG发布了新的文献求助30
11秒前
11秒前
shr完成签到,获得积分10
11秒前
Inory007发布了新的文献求助10
13秒前
13秒前
13秒前
ran123456完成签到,获得积分20
13秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974779
求助须知:如何正确求助?哪些是违规求助? 3519193
关于积分的说明 11197417
捐赠科研通 3255311
什么是DOI,文献DOI怎么找? 1797760
邀请新用户注册赠送积分活动 877150
科研通“疑难数据库(出版商)”最低求助积分说明 806187